We pour a few drops of oregano essential oil into a capsule to fight against a winter infection, we repeat the intake for two weeks, and it’s the liver that bears the brunt. The problem is not the essential oil itself, but what the liver does with it: it transforms the active molecules into metabolites that are sometimes more aggressive than the initial compound.
Hepatic Biotransformation: Why the Liver Takes the Hit First
In aromatherapy, we often talk about hepatotoxic molecules as if they directly attack liver cells. The reality is more precise. The recommendations from the DGCCRF explain that it is the biotransformation of molecules by the liver that generates toxic metabolites for hepatocytes. The liver is both the filter and the target.
Specifically, when we ingest an essential oil rich in phenols (carvacrol, eugenol, thymol), the liver mobilizes its enzymes to degrade them. At a reasonable dose and over a few days, the system holds up. With prolonged intake or at high doses, the metabolites accumulate and damage liver cells.
This mechanism also concerns molecules that are less known to the general public. Pulegone and menthofuran, present in certain mint oils (notably pennyroyal), are highlighted in official recommendations for their specific hepatic toxicity. Feedback on this point varies according to sources, but caution is warranted whenever these chemical profiles are handled.
To better understand the effects of essential oils on the liver, it is important to keep in mind that the oral route accounts for the majority of documented cases of liver damage, as the entire dose passes through the digestive system and then the liver before entering the general circulation.
Hepatotoxic Molecules in Aromatherapy: Phenols, Ketones, and Lactones
Not all essential oils present the same level of risk for the liver. Problematic molecules can be grouped into three main families.
- Phenols: carvacrol (oregano, savory), eugenol (clove, cinnamon), thymol (thymol thyme). These molecules interfere with liver enzymes and cause inflammation of hepatocytes during prolonged or overdosed oral use.
- Ketones and lactones: some oils containing pulegone (pennyroyal) or menthofuran are reported for their hepatic toxicity in health recommendations. These compounds are sometimes present in varying amounts depending on the chemotype of the plant.
- Poorly identified mixtures: Anses reminds us that many products sold as “essential oil” actually contain other ingredients (ethanol, vegetable oils), sometimes making up more than half of the composition. This opacity complicates the assessment of the real risk to the liver.
The chemotype of an essential oil varies according to the species, the part of the plant distilled, the climate, and the harvest period. Two bottles labeled “thyme” may contain very different proportions of thymol.
Oral Route, Dose, and Duration: The Three Parameters That Change Everything
It is often said that essential oils are safe “at low doses.” This is true but incomplete. The hepatic risk depends on three combined variables: the route of administration, the amount ingested, and the duration of exposure.
The oral route is the most concerning. By inhalation or diluted topical application, the amount of molecules that reaches the liver remains limited. By oral route, the entire dose passes through the liver via the portal circuit. This is known as the first-pass hepatic effect.
The duration exacerbates the problem. A one-time intake of two or three days, at the recommended doses, generally does not cause measurable damage. Beyond five to seven consecutive days by oral route, the risk increases, especially with oils rich in phenols. Health recommendations emphasize this point: hepatic toxicity is dose-dependent and time-dependent.
For individuals suffering from liver disease (cirrhosis, hepatitis, steatosis), the margin of tolerance is even more reduced. Anses recommendations indicate avoiding the use of these oils without medical advice in cases of liver insufficiency, even without documented serious history.
At-Risk Profiles and Drug Interactions with Essential Oils
Individual factors significantly modify the liver’s response. Certain populations need to exercise extra caution.
- People on medication metabolized by the liver: essential oils can interfere with cytochrome P450 enzymes, altering the effectiveness or toxicity of certain medications.
- Pregnant women and young children: their hepatic detoxification system is immature or challenged differently, increasing vulnerability to toxic metabolites.
- People with chronic liver diseases: even a dose considered low in a healthy subject can cause worsening in an already weakened liver.
Interactions between several essential oils taken simultaneously are also often underestimated. Combining an oil rich in phenols with another containing ketones multiplies the liver’s workload without the dosage of each oil taken in isolation seeming excessive.
Concrete Precautions to Protect the Liver in Aromatherapy
Rather than listing generalities, here are the reflexes that make a difference in practice. Limit any oral intake of phenolic oils to a maximum of five days, unless otherwise advised by a healthcare professional trained in aromatherapy. Always associate a hepatoprotective oil (lemon zest is often cited in protocols) during oral treatment with phenolic oils.
Check the exact chemotype on the bottle before each use. A linalool thyme and a thymol thyme have very different hepatic impacts. The former is considered gentle, while the latter requires strict precautions.
Prefer diluted topical application or inhalation for daily uses. Reserve the oral route for situations that truly justify it, for short durations, with precise dosing.
The best protection remains knowing the molecules contained in each bottle. The liver does not differentiate between a natural product and a synthetic product: it metabolizes everything that comes its way, and it is this transformation that can become a problem when the limits of dose and duration are not respected.